These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 2824765
1. Stimulation of the pituitary-adrenal axis with arginine vasopressin in patients with depression. Meller WH, Kathol RC, Jaeckle RS, Lopez JF. J Psychiatr Res; 1987; 21(3):269-77. PubMed ID: 2824765 [Abstract] [Full Text] [Related]
2. Pituitary-adrenal axis response to arginine vasopressin in patients with major depression. Carroll BT, Meller WH, Kathol RG, Gehris TL, Carter JL, Samuelson SD, Pitts AF. Psychiatry Res; 1993 Feb; 46(2):119-26. PubMed ID: 8387217 [Abstract] [Full Text] [Related]
4. Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects. Gispen-de Wied CC, Westenberg HG, Koppeschaar HP, Thijssen JH, van Ree JM. Eur Neuropsychopharmacol; 1992 Dec; 2(4):411-9. PubMed ID: 1336998 [Abstract] [Full Text] [Related]
5. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects. Rubin RT, O'Toole SM, Rhodes ME, Sekula LK, Czambel RK. Psychiatry Res; 1999 Dec 13; 89(1):1-20. PubMed ID: 10643873 [Abstract] [Full Text] [Related]
6. HPA axis abnormalities in depressed patients with normal response to the DST. Meller W, Kathol RG, Jaeckle RS, Grambsch P, Lopez JF. Am J Psychiatry; 1988 Mar 13; 145(3):318-24. PubMed ID: 2830798 [Abstract] [Full Text] [Related]
7. Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder. Akner G, Ljunggren JG, Kjellman BF, Undén F, Wetterberg L. Acta Psychiatr Scand; 1988 Apr 13; 77(4):404-10. PubMed ID: 2839010 [Abstract] [Full Text] [Related]
8. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers. Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ. J Affect Disord; 2013 Dec 13; 151(3):1108-12. PubMed ID: 23866302 [Abstract] [Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM. Metabolism; 1996 Mar 13; 45(3):351-6. PubMed ID: 8606643 [Abstract] [Full Text] [Related]
10. Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Maes M, Meltzer HY, D'Hondt P, Cosyns P, Blockx P. Psychoneuroendocrinology; 1995 Mar 13; 20(2):149-67. PubMed ID: 7899535 [Abstract] [Full Text] [Related]
11. Activation of pituitary-adrenal function in fetal sheep by corticotrophin-releasing factor and arginine vasopressin. Brooks AN, White A. J Endocrinol; 1990 Jan 13; 124(1):27-35. PubMed ID: 2153748 [Abstract] [Full Text] [Related]
12. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man. Inder WJ, Ellis MJ, Evans MJ, Donald RA. Clin Endocrinol (Oxf); 1995 Oct 13; 43(4):425-31. PubMed ID: 7586616 [Abstract] [Full Text] [Related]
13. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides. Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA. Clin Endocrinol (Oxf); 1995 Sep 13; 43(3):283-90. PubMed ID: 7586596 [Abstract] [Full Text] [Related]
14. Plasmatic vasopressin neurophysin in depression: basic levels and relations with HPA axis. Laruelle M, Seghers A, Goffinet S, Bouchez S, Legros JJ. Biol Psychiatry; 1990 Jun 01; 27(11):1249-63. PubMed ID: 2354230 [Abstract] [Full Text] [Related]
15. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Roy M, Collier B, Roy A. Psychiatry Res; 1990 Jan 01; 31(1):31-7. PubMed ID: 2156275 [Abstract] [Full Text] [Related]
16. Abnormal pituitary function during melancholia: reduced alpha-melanocyte-stimulating hormone secretion and increased intact ACTH non-suppression. Maes M, DeJonckheere C, Vandervorst C, Schotte C, Cosyns P, Raus J, Suy E. J Affect Disord; 1991 Jul 01; 22(3):149-57. PubMed ID: 1655852 [Abstract] [Full Text] [Related]
17. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency. Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP. Adv Biochem Psychopharmacol; 1987 Jul 01; 43():183-200. PubMed ID: 3035886 [Abstract] [Full Text] [Related]
18. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity. Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F. Psychoneuroendocrinology; 2017 Apr 01; 78():39-47. PubMed ID: 28167369 [Abstract] [Full Text] [Related]